The San Diego Union-Tribune |
ViaCyte raises $80 million for diabetes therapy
The San Diego Union-Tribune Diabetes therapy developer ViaCyte has raised $80 million, its largest financing to date, the San Diego biomedical company said Wednesday. ViaCyte will use the money to advance its stem cell-derived therapies, said Paul Laikind, president and CEO of ... ViaCyte Secures $80 Million Financing to Advance Functional Cures for Insulin-Requiring Diabetes |
from diabetes - Google News
Social Plugin